Uterine fibroid
Conditions
Interventions
Intravenous Tranexamic acid
Sponsors
Onwukwe Emeka
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1) Consenting women scheduled to have abdominal (laparotomy and ) myomectomy 2) uterine size of 16 weeks and above with multiple uterine fibroids
Exclusion criteria
Exclusion criteria: 1) women with known allergy to Tranexamic acid 2) women with current and / or previous thromboembolic disease 3) women with bleeding disorders 4) women taking combine oral contraceptive pills 5) women who had received Gonadotrophin Releasing hormone analogue within three month of the proposed surgery 6) women who are receiving Tranexamic acid for menorrhagia within one month of surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Estimated intraoperative blood loss | — |
Secondary
| Measure | Time frame |
|---|---|
| Packed cell volume postoperative;Number of participants requiring blood transfusion;The number of units of whole blood transfused;Duration of sugery | — |
Countries
Nigeria
Contacts
Public ContactOnyedikachi Ezirim
Resident Doctor
Outcome results
None listed